Halodoc raises US$65mil in Series B funding
By Digital News Asia March 6, 2019
- Teamed with more than 1,400 hospitals and healthcare providers in Indonesia
- Will use the new funds to perfect the online to offline healthcare experience
HALODOC, an Indonesia-based healthcare platform, has raised US$65 million (RM264.8 million) in Series B funding, led by new investor UOB Venture Management. Other new investors in the financing round include Singtel Innov8, Korea Investment Partners and WuXi AppTec. Existing investors also participated.
Halodoc is a digital healthcare platform that includes a mobile app and website allowing customers across Indonesia to have live consultations with more than 20,000 licensed doctors in the country, anytime, anywhere.
Its platform usage grew by 2500% in 2018, demonstrating robust demand for healthcare convenience.
Customers can order lab tests to be carried out in their home and use the app to order medication from 1,300 participating pharmacies, which can be delivered within an hour.
Halodoc has teamed with more than 1,400 hospitals and healthcare providers in a nationwide partnership to improve the hospital visit experience. The partnership provides customers with shortened wait times at the pharmacy post appointment and a cashless hospital visit through linking of insurance benefits.
Halodoc will use the new funds to perfect the online to offline healthcare experience with hospitals and insurance partners as its roll-out continues in 2019.
Halodoc was named "Most Innovative Start-up in Asia in November 2018" by Galen Growth Asia, an organisation that monitors the healthcare start-up ecosystem in Asia Pacific.
Halodoc founder and chief executive officer Jonathan Sudharta, said, "Today, we provide two million customers with convenient and reliable healthcare services monthly, of which half reside outside Java. There is a huge potential for technology to extend the reach of conventional healthcare, providing better access for the archipelago's large population.
“The strategic investments and partnerships will enable us to accelerate our efforts in building a platform that improves access and convenience to millions of Indonesian customers."
UOB Venture Management managing director and chief executive officer Kian-Wee Seah, said, "Halodoc's vision is to use technology to make quality healthcare more accessible for everyone and to optimize finite healthcare resources in a vast country such as Indonesia. This investment in Halodoc is a reflection of our responsible investing approach to support economic and social development."